Financing, Equity Capital Markets

New Amsterdam Pharma N.V.

02/24
|
$201.5 Million
New Amsterdam Pharma N.V.
Piper Sandler served as bookrunner for New Amsterdam Pharma N.V. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma